(Press-News.org) CAMBRIDGE, MA -- MIT engineers have developed a fuel cell that runs on the same sugar that powers human cells: glucose. This glucose fuel cell could be used to drive highly efficient brain implants of the future, which could help paralyzed patients move their arms and legs again.
The fuel cell, described in the June 12 edition of the journal PLoS ONE, strips electrons from glucose molecules to create a small electric current. The researchers, led by Rahul Sarpeshkar, an associate professor of electrical engineering and computer science at MIT, fabricated the fuel cell on a silicon chip, allowing it to be integrated with other circuits that would be needed for a brain implant.
The idea of a glucose fuel cell is not new: In the 1970s, scientists showed they could power a pacemaker with a glucose fuel cell, but the idea was abandoned in favor of lithium-ion batteries, which could provide significantly more power per unit area than glucose fuel cells. These glucose fuel cells also utilized enzymes that proved to be impractical for long-term implantation in the body, since they eventually ceased to function efficiently.
The new twist to the MIT fuel cell described in PLoS ONE is that it is fabricated from silicon, using the same technology used to make semiconductor electronic chips. The fuel cell has no biological components: It consists of a platinum catalyst that strips electrons from glucose, mimicking the activity of cellular enzymes that break down glucose to generate ATP, the cell's energy currency. (Platinum has a proven record of long-term biocompatibility within the body.) So far, the fuel cell can generate up to hundreds of microwatts — enough to power an ultra-low-power and clinically useful neural implant.
"It will be a few more years into the future before you see people with spinal-cord injuries receive such implantable systems in the context of standard medical care, but those are the sorts of devices you could envision powering from a glucose-based fuel cell," says Benjamin Rapoport, a former graduate student in the Sarpeshkar lab and the first author on the new MIT study.
Rapoport calculated that in theory, the glucose fuel cell could get all the sugar it needs from the cerebrospinal fluid (CSF) that bathes the brain and protects it from banging into the skull. There are very few cells in the CSF, so it's highly unlikely that an implant located there would provoke an immune response. There is also significant glucose in the CSF, which does not generally get used by the body. Since only a small fraction of the available power is utilized by the glucose fuel cell, the impact on the brain's function would likely be small.
A team of researchers at Brown University, Massachusetts General Hospital and other institutions recently demonstrated that paralyzed patients could use a brain-machine interface to move a robotic arm; those implants have to be plugged into a wall outlet.
Mimicking biology with microelectronics
Sarpeshkar's group is a leader in the field of ultra-low-power electronics, having pioneered such designs for cochlear implants and brain implants. "The glucose fuel cell, when combined with such ultra-low-power electronics, can enable brain implants or other implants to be completely self-powered," says Sarpeshkar, author of the book "Ultra Low Power Bioelectronics." This book discusses how the combination of ultra-low-power and energy-harvesting design can enable self-powered devices for medical, bio-inspired and portable applications.
Sarpeshkar's group has worked on all aspects of implantable brain-machine interfaces and neural prosthetics, including recording from nerves, stimulating nerves, decoding nerve signals and communicating wirelessly with implants. One such neural prosthetic is designed to record electrical activity from hundreds of neurons in the brain's motor cortex, which is responsible for controlling movement. That data is amplified and converted into a digital signal so that computers — or in the Sarpeshkar team's work, brain-implanted microchips — can analyze it and determine which patterns of brain activity produce movement.
The fabrication of the glucose fuel cell was done in collaboration with Jakub Kedzierski at MIT's Lincoln Laboratory. "This collaboration with Lincoln Lab helped make a long-term goal of mine — to create glucose-powered bioelectronics — a reality," Sarpeshkar says. Although he has just begun working on bringing ultra-low-power and medical technology to market, he cautions that glucose-powered implantable medical devices are still many years away.
INFORMATION:
Written by Anne Trafton, MIT News Office
END
(Boston) - Researchers from Boston University Schools of Medicine and Public Health (BUSM, BUSPH), along with the VA Boston Healthcare System and Harvard Medical School, have found inpatient medical procedures increased more among non-elderly, lower- and medium- income populations, Hispanics and whites, after health care reform went into effect in Massachusetts. The findings, which currently appear in Medical Care, suggest improved access to outpatient care for vulnerable subpopulations since health care reform took effect.
The 2006 Massachusetts health reform implementation ...
The U.S. Consumer Product Safety Commission, or CPSC, reports that it received fewer reports of injuries from companies in 2011. It is unclear if this is due to an actual drop in injuries or because more companies are failing to report injuries involving their products.
CBS News reports that 10 companies were fined more than $4 million in 2011, up substantially from the previous year's two companies. Companies tend to be less than enthusiastic when voluntarily reporting injuries, but the reports are required by law.
Some companies may claim they did not report certain ...
AURORA, Colo. (June 13, 2012) – Estrogen-deficient, postmenopausal women who have had their uterus removed appear to have stiffer arteries compared to similar women who have not had a hysterectomy, according to new research from the University of Colorado School of Medicine.
The finding may help explain the greater risk of cardiovascular disease, the leading cause of death in women, reported in previous research.
"The message here is that having a hysterectomy may lead to large artery stiffening, which can lead to the development of cardiovascular disease," said Kerrie ...
North-East Passage soon free from ice again? Winter measurements show thin sea ice in the Laptev Sea, pointing to early and large-scale summer melt
The North-East Passage, the sea route along the North coast of Russia, is expected to be free of ice early again this summer. The forecast was made by sea ice physicists of the Alfred Wegener Institute for Polar and Marine Research in the Helmholtz Association based on a series of measurement flights over the Laptev Sea, a marginal sea of the Arctic Ocean. Amongst experts the shelf sea is known as an "ice factory" of Arctic ...
In 2011, the U.S. Supreme Court held that people harmed by generic prescription drugs cannot sue generic manufacturers under the claim of inadequate warning labels. In PLIVA, Inc. v. Mensing, the High Court dismissed the legal claims of two women who suffered physical injury because of the inadequate warning labels on their generic medication.
While the Court ruled in 2009 that injured plaintiffs could bring state law claims against pharmaceutical companies for poor labeling on name-brand drugs, the PLIVA ruling bars similar suits against manufacturers of the generic ...
A significant number of teenagers are sending and receiving sexually explicit cell phone photos, often with little, if any, awareness of the possible psychological, interpersonal, and sometimes legal consequences of doing so. Even many of those who believe there could be serious legal consequences are undeterred and still choose to engage in 'sexting'. These findings by Donald Strassberg, from the University of Utah (US), and colleagues are published online in Springer's journal Archives of Sexual Behavior.
New communication technologies play an increasingly important ...
SAN FRANCISCO, CA—June 13, 2012—Scientists at the Gladstone Institutes today are announcing their role in an unprecedented collaboration organized by the National Institutes of Health, which used groundbreaking methods to vastly improve our understanding of bacteria that reside in and on the human body.
In a series of coordinated scientific reports, some 200 members of the Human Microbiome Project (HMP) Consortium from nearly 80 research institutions used advanced DNA-sequencing techniques to identify the thousands of microorganisms that live on humans. Researchers believe ...
Children are not just miniature versions of adults. Their rapidly-developing bodies have different physiological sensitivities, and pediatric medical care should reflect this.
However, for years, the same CT scans, fluoroscopy procedures and other X-ray imaging techniques have been used on both adults and children. Now, concerned about cancer diagnosis and other potential ill-effects of kids' exposure to radiation, the U.S. Food and Drug Administration is calling for X-ray imaging devices that take into account the unique health care needs of children.
Cancer-Causing ...
A new study eases concerns that irrigating crops with water released from sewage treatment plants — an increasingly common practice in arid areas of the world — fosters emergence of the antibiotic-resistant bacteria that cause thousands of serious infections each year. The research appears in ACS' journal Environmental Science & Technology.
Eddie Cytryn and colleagues explain that a large fraction of antibiotics given to people or animals pass out of the body unchanged in the urine and are transferred via sewage systems to wastewater treatment facilities. These facilities ...
A long-used anti-cancer drug could be a starting point to develop new treatments for the incurable nerve disease known as Lou Gehrig's disease or amyotrophic lateral sclerosis (ALS), scientists are reporting. Their research showing how the drug prevents clumping of an enzyme linked to ALS appears in the Journal of the American Chemical Society.
Lucia Banci, Ivano Bertini and colleagues explain that ALS causes a progressive loss of muscle control as the nerves that control body movements wither and die. Patients become weak and have difficulty swallowing and breathing, ...
